Kids’ Mental Health During COVID; Dirty Air and Dementia; Back-to-Work Stress
Across the globe, an estimated 25.2% of children and adolescents suffer from depression, and over 20% battle anxiety symptoms during the COVID-19 pandemic. (JAMA Pediatrics) The investigational NMDA receptor antagonist AXS-05 succeeded for treatment-resistant depression versus placebo in the 44-participant, phase III MERIT trial, Axsome Therapeutics announced. However, the FDA sent a letter to Axsome […]